Medidata: research partnership with TD2
Medidata, a Dassault Systèmes company, has announced an agreement with contract research organization Translational Drug Development (TD2) t to adopt Medidata’s Rave CTMS (Clinical Trial Management System) and eTMF (electronic Trial Master File) solutions.
Stephen Gately, TD2 president and CEO, said, “TD2 has worked with Medidata using their Rave EDC (Electronic Data Capture) system for many years; the addition of Medidata’s CTMS and eTMF platforms will allow for even more standardization across data management and clinical operations, creating efficiency, while reducing integration time and resources…This partnership improves our ability to provide valuable, data-driven insights to our clients, which is critical to the success of clinical trial design and execution.”
